MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study

BACKGROUND: While buprenorphine/naloxone (B/N) is approved for opioid use disorder treatment, effective delivery of B/N comes with significant challenges. Most notably, many patients do not take medication daily as prescribed; this non-adherence worsens treatment outcomes, increases healthcare costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuman-Olivier, Zev, Borodovsky, Jacob T., Steinkamp, Jackson, Munir, Qays, Butler, Kyle, Greene, Mary Ann, Goldblatt, Jonah, Xie, Hai Yi, Marsch, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154900/
https://www.ncbi.nlm.nih.gov/pubmed/30249279
http://dx.doi.org/10.1186/s13722-018-0122-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154900/
https://www.ncbi.nlm.nih.gov/pubmed/30249279
http://dx.doi.org/10.1186/s13722-018-0122-4

Ejemplares similares